Drugs / adult diphtheria, tetanus and acellular pertussis vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00714064 Background | Jun 2006 → Feb 2011 | otitis media with effusion, pneumococcal infection, tympanic membrane disorder | Menzies School of Health Research | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adult diphtheria, tetanus and acellular pertussis vaccine | “The adult diphtheria, tetanus and acellular pertussis vaccine (dTpa) will be used as the control vaccine for the birth dose.” NCT00714064 ↗ |
| Known as | dTpa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00714064 ↗ |
| Modality | Vaccine | “The adult diphtheria, tetanus and acellular pertussis vaccine (dTpa) will be used as the control vaccine for the birth dose.” NCT00714064 ↗ |